Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
atrasentan endothelin-1 receptor small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Malignant neoplasm of prostate[MeSHID:D011471]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.07 investigational unknown
atrasentan endothelin a receptor NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Malignant neoplasm of prostate[MeSHID:D011471]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.07 phase 3 antagonist
atrasentan endothelin-1 receptor small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Malignant neoplasm of prostate[MeSHID:D011471]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.07 investigational antagonist
atrasentan endothelin a receptor NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Malignant neoplasm of prostate[MeSHID:D011471]
Diabetic Nephropathy[MeSHID:D003928]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 7.07 phase 3 unknown
click here to return to the previous page